Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
122.75
-1.78 (-1.43%)
At close: Apr 18, 2024, 4:00 PM
122.51
-0.24 (-0.20%)
After-hours: Apr 18, 2024, 7:59 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 133, with a low estimate of 115 and a high estimate of 163. The average target predicts an increase of 8.35% from the current stock price of 122.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Buy | 1 | 2 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +30.35% | Apr 18, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $163 | Buy | Initiates | $163 | +32.79% | Apr 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +30.35% | Apr 5, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +30.35% | Apr 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +30.35% | Mar 20, 2024 |
Financial Forecast
Revenue This Year
291.47B
from 232.26B
Increased by 25.49%
Revenue Next Year
351.98B
from 291.47B
Increased by 20.76%
EPS This Year
23.64
from 18.62
Increased by 26.94%
EPS Next Year
28.81
from 23.64
Increased by 21.87%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 317.2B | 402.7B | 483.4B | 504.2B | 575.1B |
| Avg | 291.5B | 352.0B | 411.7B | 398.7B | 438.3B |
| Low | 271.7B | 314.1B | 351.4B | 326.1B | 359.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.6% | 38.2% | 37.3% | 22.5% | 44.2% |
| Avg | 25.5% | 20.8% | 17.0% | -3.2% | 9.9% |
| Low | 17.0% | 7.8% | -0.2% | -20.8% | -9.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.57 | 33.50 | 41.81 | 38.17 | 42.38 |
| Avg | 23.64 | 28.81 | 34.56 | 33.54 | 36.21 |
| Low | 21.56 | 24.16 | 27.39 | 26.49 | 28.95 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 42.7% | 41.7% | 45.1% | 10.4% | 26.4% |
| Avg | 26.9% | 21.9% | 20.0% | -3.0% | 8.0% |
| Low | 15.8% | 2.2% | -4.9% | -23.3% | -13.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.